NASDAQ: STIM
Neuronetics, Inc.
Healthcare · Medical - Diagnostics & Research
After hours: $1.26(+2.44%) · as of 7:51 PM ET
Market Cap
$85.59M
52w High
$4.85
52w Low
$0.80
P/E
-2.31
Volume
1.61M
Outstanding Shares
69.59M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 63.61% over the last year. Revenue grew 69.52% over the trailing twelve months. Operating margin moved from -43.29% to -19.4%. Free cash flow grew 63.58% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -19.4%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
5
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est -$0.11 · Revenue est $40.09M
View